BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2008
View Archived Issues
Escitalopram effective in treating multisomatoform disorder
Read More
NK-012 evaluated in phase I study in advanced cancer patients
Read More
Ki-20227 shows rheumatoid arthritis treatment potential in vivo
Read More
Recent patents describe new treatments for cardiovascular disorders
Read More
New therapeutic agents for genitourinary disorders reported in recent Roche patent
Read More
Florida International University patent discloses novel free radical scavengers
Read More
Otsuka and OncoTherapy Science enter license agreement for pancreatic cancer vaccine
Read More
Exercise-induced NMDA receptor activity prevents mature motor unit death in SMA
Read More
Bone Medical reports positive data from second clinical trial of CaPTHymone for osteoporosis
Read More
Epix reaches agreement with FDA for resubmission of Vasovist NDA
Read More
Solvay submits complete response to FDA approvable letter for Luvox CR
Read More
Eisai temporarily withdraws Japanese application for Pariet to conduct additional study
Read More
European Commission approves Novartis' Galvus as oral treatment for type 2 diabetes
Read More
Auris Medical completes patient enrollment in phase I/II trial with AM-101
Read More
Glenmark to get back global rights to melogliptin from Merck Serono
Read More
Pipex to meet with FDA following non acceptance of Coprexa NDA
Read More
Asmanex Twisthaler approved for asthma maintenance treatment in children
Read More
FDA grants orphan drug designation to VQD-002 in multiple myeloma
Read More
EU Commission grants broad approval of Xeloda in metastatic colorectal cancer
Read More
FDA approves Endeavor zotarolimus-eluting stent for clogged arteries
Read More
BioLineRx reports positive results from phase IIa BL-1020 trial in schizophrenia
Read More
Genzyme and Isis granted Hart-Scott-Rodino clearance for collaboration agreeement
Read More
First patient dosed in phase II trial of AGI-004 in chemotherapy-induced diarrhea
Read More
MedImmune submits BLA for motavizumab in the U.S.
Read More
EMEA grants positive opinion for GSK's Hycamtin in relapsed SCLC
Read More
